{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:51:46Z","timestamp":1780145506827,"version":"3.54.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T00:00:00Z","timestamp":1291334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10620-010-1501-1","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T09:03:29Z","timestamp":1291280609000},"page":"545-554","source":"Crossref","is-referenced-by-count":72,"title":["Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis"],"prefix":"10.1007","volume":"56","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Practice guidelines of the American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u20132213.","journal-title":"Hepatology"},{"key":"1501_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. AASLD practice guidelines. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"1501_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0016-5085(95)90020-9","volume":"108","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology. 1995;108:157\u2013164.","journal-title":"Gastroenterology"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0002-9343(90)90288-O","volume":"89","author":"CA Laskin","year":"1990","unstructured":"Laskin CA, Vidins E, Blendis LM, Soloninka CA. Autoantibodies in alcoholic liver disease. Am J Med. 1990;89:129\u2013133.","journal-title":"Am J Med"},{"key":"1501_CR5","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","volume":"48","author":"P Loria","year":"2003","unstructured":"Loria P, Lonardo A, Leonardi F, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173\u20132181.","journal-title":"Dig Dis Sci"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","volume":"99","author":"LA Adams","year":"2004","unstructured":"Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2004;99:1316\u20131320.","journal-title":"Am J Gastroenterol"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","volume":"38","author":"SJ Cotler","year":"2004","unstructured":"Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol. 2004;38:801\u2013804.","journal-title":"J Clin Gastroenterol"},{"key":"1501_CR8","first-page":"553","volume":"55","author":"RM Bernstein","year":"1984","unstructured":"Bernstein RM, Neuberger JM, Bunn CC, et al. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol. 1984;55:553\u2013560.","journal-title":"Clin Exp Immunol"},{"key":"1501_CR9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","volume":"23","author":"KM Boberg","year":"1996","unstructured":"Boberg KM, Fausa O, Haaland T, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology. 1996;23:1369\u20131376.","journal-title":"Hepatology"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1023\/A:1005670111068","volume":"46","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Santrach PJ, Breanndan Moore S. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci. 2001;46:140\u2013147.","journal-title":"Dig Dis Sci"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","volume":"16","author":"F Lunel","year":"1992","unstructured":"Lunel F, Abuaf N, Frangeul L, et al. Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 1992;16:630\u2013636.","journal-title":"Hepatology"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0168-8278(05)80281-8","volume":"18","author":"N Abuaf","year":"1993","unstructured":"Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol. 1993;18:359\u2013364.","journal-title":"J Hepatol"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","volume":"46","author":"PS Leung","year":"2007","unstructured":"Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology. 2007;46:1436\u20131442.","journal-title":"Hepatology"},{"key":"1501_CR14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","volume":"48","author":"C O\u2019Brien","year":"2008","unstructured":"O\u2019Brien C, Joshi S, Feld JJ, et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology. 2008;48:550\u2013556.","journal-title":"Hepatology"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","volume":"42","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol. 2008;42:1047\u20131053.","journal-title":"J Clin Gastroenterol"},{"key":"1501_CR16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","volume":"125","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588\u2013598.","journal-title":"Ann Intern Med"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","volume":"28","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28:360\u2013365.","journal-title":"Hepatology"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1089-3261(02)00031-4","volume":"6","author":"J Heathcote","year":"2002","unstructured":"Heathcote J. Variant syndromes of autoimmune hepatitis. Clin Liver Dis. 2002;6:669\u2013684.","journal-title":"Clin Liver Dis"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11894-999-0089-0","volume":"1","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep. 1999;1:63\u201370.","journal-title":"Curr Gastroenterol Rep"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","volume":"49","author":"Z Ben-Ari","year":"2001","unstructured":"Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut. 2001;49:589\u2013594.","journal-title":"Gut"},{"key":"1501_CR21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u2013938.","journal-title":"J Hepatol"},{"key":"1501_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176.","journal-title":"Hepatology"},{"key":"1501_CR23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","volume":"48","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540\u20131548.","journal-title":"Hepatology"},{"key":"1501_CR24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","volume":"42","author":"L Muratori","year":"1998","unstructured":"Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB. Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998;42:721\u2013726.","journal-title":"Gut"},{"key":"1501_CR25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol. 1999;30:394\u2013401.","journal-title":"J Hepatol"},{"key":"1501_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00004836-200310000-00011","volume":"37","author":"AJ Czaja","year":"2003","unstructured":"Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol. 2003;37:315\u2013329.","journal-title":"J Clin Gastroenterol"},{"key":"1501_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/1744666X.2.1.33","volume":"2","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ. The role of autoantibodies as diagnostic markers of autoimmune hepatitis. Expert Rev Clin Immunol. 2006;2:33\u201348.","journal-title":"Expert Rev Clin Immunol"},{"key":"1501_CR28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","volume":"103","author":"AJ Czaja","year":"1992","unstructured":"Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992;103:1290\u20131295.","journal-title":"Gastroenterology"},{"key":"1501_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. Practice guidelines of the American Association for the Study of Liver Diseases. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479\u2013497.","journal-title":"Hepatology"},{"key":"1501_CR30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335\u20131374.","journal-title":"Hepatology"},{"key":"1501_CR31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u2013662.","journal-title":"Hepatology"},{"key":"1501_CR32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993;105:1824\u20131832.","journal-title":"Gastroenterology"},{"key":"1501_CR33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u2013678.","journal-title":"Hepatology"},{"key":"1501_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07853890802552437","volume":"41","author":"R Ali","year":"2009","unstructured":"Ali R, Cusi K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ann Med. 2009;41:265\u2013278.","journal-title":"Ann Med"},{"key":"1501_CR35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0168-8278(98)80004-4","volume":"29","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 1998;29:198\u2013206.","journal-title":"J Hepatol"},{"key":"1501_CR36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology. 2010;51:307\u2013328.","journal-title":"Hepatology"},{"key":"1501_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","volume":"120","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology. 2001;120:239\u2013249.","journal-title":"Gastroenterology"},{"key":"1501_CR38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","volume":"42","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997;42:1688\u20131696.","journal-title":"Dig Dis Sci"},{"key":"1501_CR39","first-page":"993","volume":"122","author":"HA Homburger","year":"1998","unstructured":"Homburger HA, Cahen YD, Griffiths J, Jacob GL. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med. 1998;122:993\u2013999.","journal-title":"Arch Pathol Lab Med"},{"key":"1501_CR40","first-page":"1206","volume":"90","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol. 1995;90:1206\u20131211.","journal-title":"Am J Gastroenterol"},{"key":"1501_CR41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","volume":"7","author":"JC Homberg","year":"1987","unstructured":"Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis. Hepatology. 1987;7:1333\u20131339.","journal-title":"Hepatology"},{"key":"1501_CR42","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991;88:1370\u20131378.","journal-title":"J Clin Invest"},{"key":"1501_CR43","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522\u20131528.","journal-title":"Gastroenterology"},{"key":"1501_CR44","first-page":"221","volume":"55","author":"S Mishima","year":"2008","unstructured":"Mishima S, Omagari K, Ohba K, et al. Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study. Hepatogastroenterology. 2008;55:221\u2013227.","journal-title":"Hepatogastroenterology"},{"key":"1501_CR45","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","volume":"21","author":"S Nezu","year":"2006","unstructured":"Nezu S, Tanaka A, Yasui H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:1448\u20131454.","journal-title":"J Gastroenterol Hepatol"},{"key":"1501_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s005350170151","volume":"36","author":"H Miyakawa","year":"2001","unstructured":"Miyakawa H, Kikuchi K, Jong-Hon K, et al. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis. J Gastroenterol. 2001;36:33\u201338.","journal-title":"J Gastroenterol"},{"key":"1501_CR47","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","volume":"55","author":"C Dahnrich","year":"2009","unstructured":"Dahnrich C, Pares A, Caballeria L, et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009;55:978\u2013985.","journal-title":"Clin Chem"},{"key":"1501_CR48","doi-asserted-by":"crossref","unstructured":"Liu H, Norman GL, Shums Z, et al. PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;(Epub ahead of print).","DOI":"10.1016\/j.jaut.2010.09.005"},{"key":"1501_CR49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1007185","volume":"17","author":"JC Courvalin","year":"1997","unstructured":"Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis. 1997;17:79\u201390.","journal-title":"Semin Liver Dis"},{"key":"1501_CR50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","volume":"8","author":"L Gao","year":"2008","unstructured":"Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med. 2008;8:9\u201315.","journal-title":"Clin Exp Med"},{"key":"1501_CR51","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","volume":"55","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci. 2010;55:2144\u20132161.","journal-title":"Dig Dis Sci"},{"key":"1501_CR52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-200825030-00005","volume":"25","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging. 2008;25:219\u2013239.","journal-title":"Drugs Aging"},{"key":"1501_CR53","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","volume":"97","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97:2051\u20132057.","journal-title":"Am J Gastroenterol"},{"key":"1501_CR54","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1023\/A:1018836004279","volume":"43","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ, dos Santos RM, Porto A, Santrach PJ, Moore SB. Immune phenotype of chronic liver disease. Dig Dis Sci. 1998;43:2149\u20132155.","journal-title":"Dig Dis Sci"},{"key":"1501_CR55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis. Gastroenterology. 2010;139:58\u201372.","journal-title":"Gastroenterology"},{"key":"1501_CR56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","volume":"107","author":"AJ Czaja","year":"1994","unstructured":"Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology. 1994;107:200\u2013207.","journal-title":"Gastroenterology"},{"key":"1501_CR57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol. 2004;41:677\u2013683.","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1501-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1501-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1501-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T18:04:19Z","timestamp":1711994659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1501-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1501-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}